This article discusses the role of economic appraisal in insurance based health care systems, taking the case of the Netherlands as an example.
The public health insurance system in this country is governed by the Health Insurance Executive Board, which policies are firmly based on the results of economic appraisal.
Furthermore, reimbursement policies regarding pharmaceutical products are described, emphasizing again the position of information from economic appraisal in these policies.
The article concludes with the identification of some trends in health policy and in the way it is supported by economic appraisal studies.
Mots-clés Pascal : Système santé, Economie santé, Analyse économique, Politique sanitaire, Assurance maladie, Pays Bas, Médicament, Remboursement, Europe
Mots-clés Pascal anglais : Health system, Health economy, Economic analysis, Health policy, Health insurance, Netherlands, Drug, Europe
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0354800
Code Inist : 002B30A01B. Création : 199406.